NCT06287970View on ClinicalTrials.gov

TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS

NANot yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

February 18, 2027

Conditions
Chronic Prostatitis
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation

In the experimental group, bilateral auricular point Xin (CO15) and auricular point Shen (CO10) will be stimulated, on where the vagus nerves distributed.

DEVICE

Sham Transcutaneous Auricular Vagus Nerve Stimulation

In the control group, bilateral earlobes will be stimulated with no vagus nerve distribution.

Trial Locations (1)

100053

Guang'anmen Hospita, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
lead

Jiani Wu

OTHER

NCT06287970 - TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS | Biotech Hunter | Biotech Hunter